Yüklüyor......
Intra‐arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial
BACKGROUND: There are no known treatments that halt or reverse chronic kidney disease (CKD) in cats. In rodent models, stem cell treatment has been associated with improvement in renal function parameters, especially when stem cells were delivered intra‐arterially to the kidney. To date, only IV and...
Kaydedildi:
| Yayımlandı: | J Vet Intern Med |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Inc.
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524114/ https://ncbi.nlm.nih.gov/pubmed/30924554 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.15486 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|